Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May;17(5):2150-7.
doi: 10.1091/mbc.e05-12-1107. Epub 2006 Feb 22.

Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death

Affiliations

Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death

Christine Bonzon et al. Mol Biol Cell. 2006 May.

Abstract

The mechanisms through which Caspase-2 leads to cell death are controversial. Here we show, using a combination of cell-free and cell culture-based approaches, that cleavage of the Bcl-2-family protein Bid is required for the induction of apoptosis by Caspase-2. Caspase-2 promoted cytochrome c release from mitochondria in the presence of cytosol from wild-type, but not Bid-deficient, mouse embryonic fibroblasts (MEFs). Recombinant wild-type Bid, but not a noncleavable mutant (D59E), restored cytochrome c release. Similarly, Bid-null MEFs were relatively resistant to apoptosis triggered by active Caspase-2, and apoptosis was restored in Bid-null cells by the expression of wild-type, but not D59E, Bid. Finally, Bid-null MEFs were substantially more resistant to apoptosis induced by heat shock, which has been shown to be dependent on apical activation of Caspase-2. The data are consistent with a model in which Caspase-2 induces apoptosis via cleavage of Bid at D59 and the subsequent engagement of the mitochondrial (intrinsic) pathway.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Caspase-2 induces MOMP in isolated mitochondria, in the presence of cytosol, that is blocked by Bcl-xL. (A) X. laevis egg cytosolic extracts (20 mg/ml) and mitochondria (4%) were incubated with or without rCaspase-2 at 21°C for 2 h. (B) Jurkat cytosolic extracts (10 mg/ml) and Xenopus egg mitochondria (4%) were incubated with or without rCaspase-2 for 2.5 or 5 h at 21°C. (C) Jurkat cytosolic extracts (10 mg/ml) and mouse liver mitochondria (80 μg) were incubated with the indicated recombinant caspases for 1 h at 37°C. Where indicated, 6 μg of rBcl-xLΔC was used. (D) Mouse liver mitochondria (80 μg) were incubated with the indicated recombinant caspases in buffer for 1 h at 37°C. Supernatants and mitochondrial pellets were resolved by SDS-PAGE, and immunoblots were probed with an anti-cytochrome c antibody (BD Biosciences PharMingen, San Diego, CA).
Figure 2.
Figure 2.
Cytosolic factors are required for Caspase-2–induced MOMP. (A) X. laevis egg mitochondria (4%) were incubated in and treated with tBid or rCaspase-2 for 5 h at room temperature. (B) Jurkat cytosolic extracts (10 mg/ml) and mouse liver mitochondria (80 μg) were incubated with the indicated recombinant caspases for 25 and 60 min at 37°C. (C) Jurkat cytosolic extracts (10 mg/ml) were incubated with the indicated recombinant caspases for 60 min at 37°C. Samples were then treated with 100 μM zVAD-fmk and serially diluted with buffer A. Mouse liver mitochondria (80 μg) were added and the samples were incubated for 2 h at 37°C. Mitochondrial pellets are shown. Supernatants and mitochondrial pellets were resolved by SDS-PAGE, and immunoblots were probed with an anti-cytochrome c antibody (BD Biosciences PharMingen).
Figure 3.
Figure 3.
Bid and its cleavage are required for Caspase-2–induced MOMP. (A) Mouse liver mitochondria (80 μg) were incubated in cytosolic extracts (approx. 10 mg/ml) prepared from Bid+/+ or Bid–/– MEFs and treated with the indicated recombinant caspases for 1 h at 37°C. (B) X. laevis egg mitochondria (4%) were incubated in Bid–/– cytosolic extract (approx. 10 mg/ml) alone or in the presence of 1 or 2 μg/ml either GST, GST-WT Bid, or GST-D59E Bid and subjected to rCaspase-2 treatment for 3 h at 21°C. Mitochondrial pellets and supernatants were resolved by SDS-PAGE and blotted for cytochrome c using an anti-cytochrome c antibody (BD Biosciences PharMingen).
Figure 4.
Figure 4.
Caspase-2 does not cleave Bid efficiently. (A) Jurkat cytosolic extracts (10 mg/ml) and mouse liver mitochondria (80 μg) were incubated with the indicated recombinant caspases for 1 h at 37°C. Where indicated, 6 μg of rBcl-xLΔC was used. Supernatants and mitochondrial pellets were resolved by SDS-PAGE and blotted for Bid using an anti-Bid antibody (Bossy-Wetzel and Green, 1999). (B) WT or D59E Bid was in vitro transcribed, translated, and labeled with [35S]methionine. Counts (5000) were then subjected to caspase cleavage for 1 h. Samples were analyzed by phosphorimaging (bottom) and autoradiography (top).
Figure 5.
Figure 5.
Bid–/– MEFs are resistant to Caspase-2–induced death. (A) Bid+/+ and Bid–/– MEFs were transfected with 5 μg of FITC-dextrans and 0.5 or 1 μg of rCaspase-2 using the Chariot reagent. At 5 h posttransfection, cells were analyzed by flow cytometry to determine the percentage of FITC-positive cells that displayed annexin V positivity. The data were obtained from three independent experiments and error bars reflect SE. (B) Wild-type (WT) and Bid–/– MEFs were treated with either 2.5 or 3.0 mJ/cm2 of UV. At the indicated times posttreatment, cells were incubated with propidium iodide and subjected to flow cytometric analysis. In parallel, control cells were untreated with UV and/or cultured in the presence of the pan-caspase inhibitor Q-VD (20 μM; 24-h time points only). Error bars reflect SE of triplicate samples. (C) Bid+/+ and Bid–/– MEFs were transfected with 2 μg of either C2-GFP or C320G-GFP and subjected to flow cytometric analysis at 12 h posttransfection. The percentage of transfected cells that displayed annexin V positivity is shown. Error bars reflect SE; two independent experiments were performed, each in triplicate. (D) Bid–/– MEFs were cotransfected with either 2 μg of C2-GFP or C320G-GFP and 100 ng of either wild-type or D59E Bid and analyzed by flow cytometry at 12 h posttransfection. The percentage of transfected cells that displayed annexin V positivity is shown. Error bars reflect SE; two independent experiments were performed, each in triplicate.
Figure 6.
Figure 6.
Bid–/– MEFs are resistant to heat shock–induced death. (A) Wild-type (WT) and Bid–/– MEFs were heat shocked at 44°C for 1 h and then put at 37°C for the indicated times. At each time point, cells were incubated with propidium iodide and subjected to flow cytometric analysis. In parallel, control cells were pretreated with 20 μM Q-VD and/or not subjected to heat shock (24-h time points only). The percentage of PI-positive cells is shown. Error bars reflect SE of triplicate samples. (B) A model showing the dependence of Caspase-2 on Bid and its cleavage to induce cytochrome c release and subsequent cell death. Other Caspase-2 substrates may mediate low levels of Bid-independent cell death or may participate in Bid-dependent death. The pleiotropic effects of heat shock are depicted: Caspase-2 activation, leading to Bid cleavage as well as the sensitization of mitochondria to tBid-induced MOMP (Pagliari et al., 2005).

References

    1. Bergeron, L., et al. (1998). Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12, 1304–1314. - PMC - PubMed
    1. Bossy-Wetzel, E., and Green, D. R. (1999). Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J. Biol. Chem. 274, 17484–17490. - PubMed
    1. Colussi, P. A., Harvey, N. L., and Kumar, S. (1998). Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J. Biol. Chem. 273, 24535–24542. - PubMed
    1. Droin, N., Bichat, F., Rebe, C., Wotawa, A., Sordet, O., Hammann, A., Bertrand, R., and Solary, E. (2001). Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells. Blood 97, 1835–1844. - PubMed
    1. Duan, H., and Dixit, V. M. (1997). RAIDD is a new `death' adaptor molecule. Nature 385, 86–89. - PubMed

Publication types